QPS Holdings, Hepregen partner

Monday, June 3, 2013

QPS Holdings, a U.S.-based CRO, and Hepregen, developer of HepatoPac and HepatoMune “liver-in-a-dish” products, have partnered to provide QPS a license to offer drug metabolism and pharmacokinetic (DMPK) services to its clients using Hepregen’s products, in both the U.S. and Europe. The partnership also includes marketing and sales, providing co-promotion of the HepatoPac-associated DMPK services. This arrangement is the first such partnership in the field for both companies.

[Read More]